Last updated on June 2017

Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)


Brief description of study

Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)

Detailed Study Description

Nonalcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease. It is caused by excess fat in the liver that leads to inflammation and tissue injury.

People with type 2 diabetes, obesity, high cholesterol, insulin resistance, and high blood pressure may have NASH.

ACRC Trials is conducting a research study to evaluate an investigational drug for NASH.

Clinical Study Identifier: TX150235

Contact Investigators or Research Sites near you

Start Over

ACRC TRIALS

ACRC TRIALS
Dallas, TX USA
  Connect »